Compliance With Once Daily Glaucoma Medication

A study to examine patient compliance with once daily glaucoma medication

Completed

Looking for future studies?

Key information

Conditions

Compliance Behavior Health Behavior Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Sex eligibility

All sexes

Study type

Observational

Primary location

Ft. Worth

Fort Worth, Texas, 76134, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Primary open angle glaucoma or ocular hypertension patients

Exclusion criteria

None

Treatment and study plan

Intervention

Behavioral

The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Collaborators

Johns Hopkins University
University of Pennsylvania

Registry information

Important dates

Study start: 2006
Primary completion: 2007
Study completion: 2007
First posted: Jun 5, 2006
Registry last updated: Nov 18, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed